Viewing Study NCT06850051

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2026-05-17 @ 3:18 PM
Study NCT ID: NCT06850051
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-18
First Post: 2025-02-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age.
Sponsor: Sanofi
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Volunteers View
None Influenza Vaccination View
None Respiratory Syncytial Virus Vaccination View
None Parainfluenza Vaccination View
None Human Metapneumovirus Vaccination View
Keywords:

Keywords

Keyword Brief Keyword Text View
None influenza View
None respiratory syncytial virus View
None parainfluenza View
None human metapneumovirus View